Powder: -20°C for 3 years | In solvent: -80°C for 1 year
N,N'-Dicyclohexylurea (AURORA KA-3582) is a soluble epoxide hydrolase (sEH) inhibitor.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
50 mg | In stock | $ 50.00 | |
500 mg | In stock | $ 397.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 50.00 |
Description | N,N'-Dicyclohexylurea (AURORA KA-3582) is a soluble epoxide hydrolase (sEH) inhibitor. |
Synonyms | DCU, 1,3-Dicyclohexylurea, NSC 17013, Dicyclohexylurea, Dicyclohexylcarbodiamide, AURORA KA-3582 |
Molecular Weight | 224.34 |
Formula | C13H24N2O |
CAS No. | 2387-23-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 5 mg/mL (22.29 mM), with gentle warming
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
N,N'-Dicyclohexylurea 2387-23-7 Metabolism Epoxide Hydrolase Orally active N,N' Dicyclohexylurea Nanoparticle drug delivery system AURORA KA3582 AURORA KA 3582 DCU 1,3-Dicyclohexylurea NSC 17013 NSC17013 Nanosuspension Spontaneously hypertensive rats Dicyclohexylurea inhibit Dicyclohexylcarbodiamide N,N'Dicyclohexylurea Antihypertensive effect AURORA KA-3582 NSC-17013 Inhibitor inhibitor